Ghania Chikh | Senior Director, Vaccine Development
Acuitas Therapeutics, Inc.

Dr. Chikh is Senior Director of Vaccine Development at Acuitas Therapeutics, with more than 20 years of experience in vaccine and immunotherapy drug development. She leads development programs focused on mRNA vaccines and next-generation delivery platforms, including lipid nanoparticle (LNP) technologies. She holds a PhD focused on LNP-based cancer vaccines and has held leadership roles at Pfizer, Vasomune Therapeutics Inc., and enGene Inc., where she advanced multiple vaccine and gene therapy programs from discovery through clinical development. She also brings extensive expertise in regulatory strategy and IND submissions, supporting the successful translation of innovative therapies across infectious disease, oncology, and immune-mediated indications.Dr. Chikh is Senior Director of Vaccine Development at Acuitas Therapeutics, with more than 20 years of experience in vaccine and immunotherapy drug development. She leads development programs focused on mRNA vaccines and next-generation delivery platforms, including lipid nanoparticle (LNP) technologies. She holds a PhD focused on LNP-based cancer vaccines and has held leadership roles at Pfizer, Vasomune Therapeutics Inc., and enGene Inc., where she advanced multiple vaccine and gene therapy programs from discovery through clinical development. She also brings extensive expertise in regulatory strategy and IND submissions, supporting the successful translation of innovative therapies across infectious disease, oncology, and immune-mediated indications.